Citation

Rohde JM, Karavadhi S, Pragani R, Liu L, Fang Y, Zhang W, McIver A, Zheng H, Liu Q, Davis MI, Urban DJ, Lee TD, Cheff DM, Hollingshead M, Henderson MJ, Martinez NJ, Brimacombe KR, Yasgar A, Zhao W, Klumpp-Thomas C, Michael S, Covey J, Moore WJ, Stott GM, Li Z, Simeonov A, Jadhav A, Frye S, Hall MD, Shen M, Wang X, Patnaik S, Boxer MB.: Discovery and Optimization of 2<i>H</i>-1λ²-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer. J Med Chem, Volume 64 (8), 2021

Authors

Boxer MB., Brimacombe KR, Cheff DM, Covey J, Davis MI, Fang Y, Frye S, Hall MD, Henderson MJ, Hollingshead M, Jadhav A, Karavadhi S, Klumpp-Thomas C, Lee TD, Li Z, Liu L, Liu Q, Martinez NJ, McIver A, Michael S, Moore WJ, Patnaik S, Pragani R, Rohde JM, Shen M, Simeonov A, Stott GM, Urban DJ, Wang X, Yasgar A, Zhang W, Zhao W, Zheng H

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00019

PubMed

33822623

Machine-readable

REST APIRDF